AGENCY:
Office of the Secretary, HHS.
ACTION:
Notice.
SUMMARY:
Notice is hereby given that the Office of Research Integrity (ORI) and the Assistant
Secretary for Health have taken final action in the following case:
Malabika Sarker, M.B.B.S., M.P.H., University of Alabama at Birmingham: Based on the
report of an investigation conducted by the University of Alabama at Birmingham and
additional analysis conducted by ORI in its oversight review, the U.S. Public Health
Service (PHS) finds that Dr. Sarker, former doctoral fellow, Department of Epidemiology,
School of Public Health, University of Alabama at Birmingham, engaged in scientific
misconduct by falsifying questionnaire data for risk factors for sexually transmitted
diseases (STDs) in Bangladesh for her dissertation. The research was supported by
the Fogerty International Center, National Institutes of Health (NIH), grant D43 TW01035,
“UAB AIDS/HIV International Training & Research.”
The purpose of the research was to determine from questionnaires the lifestyle and
personal history factors of subjects and correlate them to infection rates for STDs
from use of laboratory tests. Dr. Sarker admitted that she falsified the coding of
the questionnaire data relating to the occupations of the subjects and of their sexual
partners to present statistically significant data regarding the risk factors for
STDs.
Dr. Sarker has accepted the PHS finding and has entered into a Voluntary Exclusion
Agreement with PHS in which she has voluntarily agreed for a period of three (3) years,
beginning on April 17, 2001:
(1) To exclude herself from serving in any advisory capacity to PHS, including but
not limited to service on any PHS advisory committee, board, and/or peer review committee;
(2) That any institution that submits an application for PHS support for a research
project on which Dr. Sarker's participation is proposed or that uses Dr. Sarker in
any capacity on PHS supported research, or that submits a report of PHS-funded research
in which Dr. Sarker is involved, must concurrently submit a plan for supervision of
her duties to the funding agency for approval. The supervisory plan must be designed
to ensure the scientific integrity of Dr. Sarker's research contribution. The institution
must also submit a copy of the supervisory plan to ORI.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative Oversight, Office of Research Integrity, 5515
Security Lane, Suite 700, Rockville, MD 20852, (301) 443-5330.
Chris Pascal,Director, Office of Research Integrity.